ebomi
Colour theme
Sign in
Insider · CIK 0001608936

Chacko Jacob

CIK 0001608936 Name as filed on the most recent filing

Filed as Chacko Jacob (30)

50 transaction lines · from 30 filings · filed 2014-08-19 to 2025-12-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

50 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-21 05:23 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-12-16 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 33,374 disposed 9.06 302,368.44 Form 4, filing 0001608936-25-000014
2025-10-06 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 37,461 disposed 12.32 461,519.52 Form 4, filing 0001608936-25-000010
2025-10-01 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 53,001 disposed 12.05 638,805.15 Form 4, filing 0001608936-25-000008
2025-09-30 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 34,538 disposed 12.01 414,749.57 Form 4, filing 0001608936-25-000008
2025-09-22 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 125,000 disposed 10.80 1,349,937.50 Form 4, filing 0001608936-25-000006
2024-12-16 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 24,660 disposed 8.28 204,214.39 Form 4, filing 0001415889-24-029631
2024-03-06 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 40,000 disposed 16.21 648,380.00 Form 4, filing 0001415889-24-007345
2024-02-07 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 26,042 disposed 12.30 320,186.39 Form 4, filing 0001415889-24-003114
2024-02-06 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 13,958 disposed 12.12 169,159.79 Form 4, filing 0001415889-24-003114
2023-12-15 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 14,539 disposed 8.58 124,812.95 Form 4, filing 0001209191-23-059263
2023-07-11 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 5,156 disposed 8.01 41,287.19 Form 4, filing 0001209191-23-042054
2023-07-10 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 10,508 disposed 8.01 84,212.16 Form 4, filing 0001209191-23-042054
2023-07-05 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 4,336 disposed 8.01 34,710.55 Form 4, filing 0001209191-23-041805
2023-06-26 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 20,000 disposed 8.03 160,562.00 Form 4, filing 0001209191-23-040090
2023-04-21 4D Molecular Therapeutics, Inc.
FDMT 		S, Open-market sale 5,000 disposed 20.05 100,269.50 Form 4, filing 0001140361-23-020315
2022-12-15 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 6,137 disposed 3.07 18,859.00 Form 4, filing 0001209191-23-010607
2022-12-15 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 5,764 disposed 3.25 18,733.00 Form 4, filing 0001209191-22-061754
2022-05-13 Oric Pharmaceuticals, Inc.
ORIC 		P, Open-market purchase 76,072 acquired 2.82 214,561.08 Form 4, filing 0001209191-22-028963
2022-05-12 Oric Pharmaceuticals, Inc.
ORIC 		P, Open-market purchase 69,354 acquired 2.75 190,466.89 Form 4, filing 0001209191-22-028963
2022-05-11 Oric Pharmaceuticals, Inc.
ORIC 		P, Open-market purchase 304,574 acquired 2.90 883,569.17 Form 4, filing 0001209191-22-028963
2022-03-25 Oric Pharmaceuticals, Inc.
ORIC 		P, Open-market purchase 50,000 acquired 4.54 227,170.00 Form 4, filing 0001209191-22-021153
2022-03-24 Oric Pharmaceuticals, Inc.
ORIC 		P, Open-market purchase 42,873 acquired 5.03 215,659.76 Form 4, filing 0001209191-22-021153
2022-03-23 Oric Pharmaceuticals, Inc.
ORIC 		P, Open-market purchase 257,127 acquired 4.98 1,280,878.15 Form 4, filing 0001209191-22-021153
2021-09-15 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 3,736 disposed 25.06 93,628.64 Form 4, filing 0001209191-21-056460
2021-09-14 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 4,420 disposed 25.05 110,706.41 Form 4, filing 0001209191-21-056460
2021-09-13 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 2,801 disposed 25.02 70,088.86 Form 4, filing 0001209191-21-055866
2021-09-10 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 2,942 disposed 25.08 73,783.30 Form 4, filing 0001209191-21-055866
2021-09-08 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 200 disposed 25.04 5,007.00 Form 4, filing 0001209191-21-055291
2021-09-07 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 5,981 disposed 25.11 150,173.34 Form 4, filing 0001209191-21-055291
2021-05-27 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 400 disposed 25.07 10,028.00 Form 4, filing 0001209191-21-036686
2021-05-24 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 12 disposed 25.00 300.00 Form 4, filing 0001209191-21-035523
2021-05-21 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 4,790 disposed 25.20 120,687.88 Form 4, filing 0001209191-21-035523
2021-05-20 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 2,468 disposed 25.07 61,863.88 Form 4, filing 0001209191-21-035523
2021-05-18 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 11,132 disposed 25.37 282,427.75 Form 4, filing 0001209191-21-033813
2021-05-18 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 200 disposed 26.03 5,206.00 Form 4, filing 0001209191-21-033813
2021-05-17 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 2,550 disposed 25.05 63,884.13 Form 4, filing 0001209191-21-033813
2021-05-14 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 13,896 disposed 25.36 352,465.09 Form 4, filing 0001209191-21-033813
2021-05-13 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 730 disposed 25.04 18,281.02 Form 4, filing 0001209191-21-032508
2021-05-12 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 400 disposed 25.02 10,009.60 Form 4, filing 0001209191-21-032508
2021-05-11 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 1,090 disposed 25.22 27,489.58 Form 4, filing 0001209191-21-032508
2021-04-30 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 600 disposed 25.24 15,142.98 Form 4, filing 0001209191-21-029375
2021-04-28 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 700 disposed 25.06 17,541.72 Form 4, filing 0001209191-21-029375
2021-04-01 Oric Pharmaceuticals, Inc.
ORIC 		S, Open-market sale 800 disposed 25.09 20,069.60 Form 4, filing 0001209191-21-025492
2016-03-17 Ignyta, Inc.
RXDX 		P, Open-market purchase 10,000 acquired 5.64 56,350.00 Form 4, filing 0001209191-16-109687
2015-12-16 Ignyta, Inc.
RXDX 		P, Open-market purchase 1,500 acquired 12.00 18,000.00 Form 4, filing 0001209191-15-085727
2015-08-20 Ignyta, Inc.
RXDX 		P, Open-market purchase 1,500 acquired 12.40 18,600.00 Form 4, filing 0001209191-15-068277
2014-11-24 Ignyta, Inc.
RXDX 		P, Open-market purchase 930 acquired 6.50 6,045.00 Form 4, filing 0001209191-14-070947
2014-11-21 Ignyta, Inc.
RXDX 		P, Open-market purchase 668 acquired 6.40 4,275.20 Form 4, filing 0001209191-14-070947
2014-08-19 Ignyta, Inc.
RXDX 		P, Open-market purchase 1,540 acquired 7.53 11,596.20 Form 4, filing 0001209191-14-053500
2014-08-15 Ignyta, Inc.
RXDX 		P, Open-market purchase 300 acquired 7.50 2,250.00 Form 4, filing 0001209191-14-053500

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 13
  • Open-market sale 37
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Chacko Jacob, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001608936

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.